Myocarditis remains an unknown disease with varying clinical manifestations, often leading to heart failure. The latest 2021 and 2022 guidelines of the European Society of Cardiology (ESC) are the first official European documents updating knowledge on the diagnosis and treatment of myocarditis since the 2013 ESC expert consensus statement. These guidelines and new studies allow standardization and improvements to the management of myocarditis. In this review, we discuss the most important aspects of myocarditis diagnosis, therapies and follow-up based on current knowledge.
All Keywords
【저자키워드】 Immunosuppression, heart failure, Endomyocardial biopsy, Personalized medicine, inflammatory cardiomyopathy, cardio-immunology,
【저자키워드】 Immunosuppression, heart failure, Endomyocardial biopsy, Personalized medicine, inflammatory cardiomyopathy, cardio-immunology,